Crossmark

New evidence on the management of spondyloarthritis

Crossref DOI link: https://doi.org/10.1038/nrrheum.2016.42

Published Online: 2016-04-07

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sieper, Joachim

Poddubnyy, Denis
License Information

Text and Data Mining valid from 2016-04-07
More Information

Article History

First Online: 7 April 2016

Competing interests

: J.S. declares that he has received honoraria, speaker fees and/or consultancy payments from Abbvie, Janssen, Eli Lilly, MSD/Merck, Novartis, Pfizer, Roche and UCB. D.P. declares that he has received honoraria, speaker fees and/or consultancy payments from Abbvie, Bristol Myers Squibb, Eli Lilly, Janssen, MSD/Merck, Novartis, Pfizer, Roche and UCB.